LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks

24/7 Biopharma had the opportunity to sit down for a long-form interview about the state of the CDMO industry with Hamilton Lenox, Chief Commercial Officer, and Matt Grazioli, Senior Marketing Manager, of LGM Pharma. The discussion touched on LGM’s recent facility expansions, shifting market demands in the CDMO segment, and how the company is responding to the uncertain state of the global economy, among various other topics.

LATEST VIDEO

Latest news

13th July 2026

Kindeva Appoints Brok Weichbrodt as Chief Transformation Officer to Accelerate Growth Strategy and Commercial Excellence

8th July 2026

Symeres and Axxam Appoint Russell Thomas as Chief Scientific Officer to lead their collaborative integrated discovery platform

7th July 2026

Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones

7th July 2026

Eppendorf Focuses Outreach Programmes to Advance STEM Education in Europe

2nd July 2026

Siddharth Mittal Appointed as Managing Director & CEO of Syngene International

2nd July 2026

Lonza Acquires Rights to Nona Biosciences’ TfR1 Blood-Brain Barrier Technology and Expands Strategic Collaboration

1st July 2026

Sunresin Opens Its First European Site in Uppsala

1st July 2026

Lonza Expands Strategic Collaboration with Leading US Biopharmaceutical Company

30th June 2026

Lonza Expands HPAPI Capacity in Visp, Further Supporting its Position in Payload-Linker Manufacturing

30th June 2026

teriMax Announces Acquisition of Andone Pharmaceuticals, Expanding Presence in Medical Device and Veterinary Markets

30th June 2026

Zerion Pharma completes royalty financing and equity investment transaction with Ligand to advance the Dispersome® technology

This week’s featured articles

Navigating Complexity: Industry Leaders on Bioprocessing, Manufacturing and Partnership Models

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Partnered with top industry events and organisations